Skip to main content
AE

AEON Biopharma

Newport Beach, United States
Last funding
$22.0M
Post-IPO EquityNov 2025

AEON Biopharma is a biopharmaceutical company that develops novel and proprietary treatment paradigms to improve patient outcomes.

Backed byDaewoong PharmaceuticalDaewoong

About AEON Biopharma

How much funding has AEON Biopharma raised?

AEON Biopharma has raised $22.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in November 2025.

Who are AEON Biopharma's investors?

AEON Biopharma's investors include Daewoong Pharmaceutical, Daewoong.

Where is AEON Biopharma headquartered?

AEON Biopharma is headquartered in Newport Beach, United States.

What does AEON Biopharma do?

AEON Biopharma is a biopharmaceutical company that develops novel and proprietary treatment paradigms to improve patient outcomes.

What stage is AEON Biopharma at?

AEON Biopharma is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"AEON Biopharma — Funding & Investors." VCBacked, November 13, 2025, https://www.vcbacked.co/company/aeon-biopharma. Accessed November 13, 2026.
APA
VCBacked. (2025). AEON Biopharma — Funding & Investors. Retrieved November 13, 2026, from https://www.vcbacked.co/company/aeon-biopharma
Wikipedia (cite web)
{{cite web |title=AEON Biopharma — Funding & Investors |url=https://www.vcbacked.co/company/aeon-biopharma |website=VCBacked |access-date=November 13, 2026}}

Profile data sourced and verified per the VCbacked methodology · Last funding round dated

Work at AEON Biopharma? Request a listing update

Founder contacts
m***@aeonbiopharma.com
linkedin.com/in/●●●●●●
Emails, phones & LinkedIn · 41,000+ verified contacts
Get instant access →